GALT · Galectin Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Richard E. Uihlein | ▲ Buy | Option Exercise | 44,713,843 Shares held | 7/31/2026 | View profile |
| 10X Fund, L.P. 10% Owner | ▼ Sell | Open Market | 5,614,457 Shares held | 12/16/2025 | View profile |
| CZIRR JAMES C 10% Owner | ▲ Buy | Option Exercise | 1,045,541 Shares held | 6/6/2025 | View profile |
| Joel Lewis President and CEO | ▼ Sell | Open Market | 832,592 Shares held | 1/6/2026 | View profile |
| Kary Eldred | ▲ Buy | Open Market | 65,682 Shares held | 2/6/2026 | View profile |
| Kevin D. Freeman | ▲ Buy | Open Market | 55,269 Shares held | 12/23/2025 | View profile |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 42,083 Shares held | 12/24/2024 | View profile |
| Jack W. Callicutt Chief Financial Officer | ▼ Sell | Open Market | 7,614 Shares held | 1/6/2026 | View profile |
| Harold H. Shlevin | ▼ Sell | Open Market | 6,500 Shares held | 6/29/2026 | View profile |
| Schwartz Elissa J. | ▲ Buy | Open Market | 1,000 Shares held | 1/21/2022 | View profile |
| Khurram Jamil Chief Medical Officer | ▼ Sell | Open Market | 0 Shares held | 7/14/2026 | View profile |
Transaction History
| Richard E. Uihlein | ▲ Buy | Option Exercise | 31,825,235 | $95.5M | 7/31/2026 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 2,550,932 | $10.3M | 7/31/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 16,250 | $83K | 7/14/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 16,250 | $49K | 7/14/2026 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 22,268 | $27K | 6/29/2026 |
| Harold H. Shlevin | ▼ Sell | Open Market | 22,268 | $112K | 6/29/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 47,467 | $119K | 6/29/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 47,467 | $239K | 6/29/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 2,037 | $10K | 6/26/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 2,037 | $4K | 6/26/2026 |
| Harold H. Shlevin | ▼ Sell | Open Market | 7,732 | $39K | 6/26/2026 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 7,732 | $10K | 6/26/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 2,533 | $6K | 6/26/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 2,533 | $13K | 6/26/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 7,557 | $24K | 6/23/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 7,557 | $9K | 6/23/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 568 | $699 | 5/26/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 568 | $2K | 5/26/2026 |
| Kary Eldred | ▲ Buy | Open Market | 300 | $810 | 2/6/2026 |
| Richard E. Uihlein | ▲ Buy | Grant | 13,158 | $40K | 1/16/2026 |
| Joel Lewis | ▼ Sell | Open Market | 37,698 | $135K | 1/6/2026 |
| Jack W. Callicutt | ▼ Sell | Open Market | 20,354 | $75K | 1/6/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 21,446 | $78K | 1/6/2026 |
| Joel Lewis | ▼ Sell | Open Market | 27,731 | $108K | 1/5/2026 |
| Jack W. Callicutt | ▼ Sell | Open Market | 25,732 | $100K | 1/5/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 25,499 | $99K | 1/5/2026 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 60,000 | $0 | 1/2/2026 |
| Joel Lewis | ▲ Buy | Option Exercise | 84,000 | $0 | 1/2/2026 |
| Joel Lewis | ▼ Sell | Open Market | 18,571 | $78K | 1/2/2026 |
| Jack W. Callicutt | ▼ Sell | Open Market | 13,914 | $58K | 1/2/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 13,055 | $55K | 1/2/2026 |
| Khurram Jamil | ▲ Buy | Option Exercise | 60,000 | $0 | 1/2/2026 |
| Khurram Jamil | ▼ Sell | Open Market | 8,125 | $33K | 12/31/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 8,125 | $10K | 12/31/2025 |
| Kary Eldred | ▲ Buy | Open Market | 700 | $3K | 12/23/2025 |
| Kevin D. Freeman | ▲ Buy | Open Market | 5,500 | $20K | 12/23/2025 |
| Kary Eldred | ▲ Buy | Open Market | 700 | $3K | 12/23/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 8,500 | $60K | 12/17/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 20,000 | $40K | 12/17/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 19,793 | $139K | 12/17/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 7,829 | $22K | 12/17/2025 |
| Joel Lewis | ▼ Sell | Open Market | 7,829 | $55K | 12/17/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 4,479 | $32K | 12/17/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 6,463 | $14K | 12/17/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 8,500 | $21K | 12/17/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 4,706 | $33K | 12/17/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 6,463 | $45K | 12/17/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 30,681 | $204K | 12/16/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 8,417 | $35K | 12/15/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 8,417 | $53K | 12/15/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 19,793 | $82K | 12/12/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 19,793 | $124K | 12/12/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 16,790 | $70K | 12/9/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 16,790 | $105K | 12/9/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 25,000 | $149K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 35,000 | $74K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 35,000 | $211K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 20,000 | $120K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 35,000 | $100K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 35,000 | $208K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 20,000 | $42K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 20,000 | $119K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 20,000 | $40K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 20,000 | $119K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 25,000 | $43K | 12/8/2025 |
| Harold H. Shlevin | ▲ Buy | Option Exercise | 20,000 | $22K | 12/8/2025 |
| Harold H. Shlevin | ▼ Sell | Open Market | 4,000 | $24K | 12/8/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 120,000 | $688K | 12/3/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 30,000 | $164K | 12/2/2025 |
| 10X Fund, L.P. | ▼ Sell | Other | 24,000 | — | 11/24/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 6,783 | $16K | 11/18/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 18,210 | $113K | 11/18/2025 |
| Joel Lewis | ▼ Sell | Open Market | 6,783 | $42K | 11/18/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 28,100 | $56K | 11/18/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 28,100 | $175K | 11/18/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 18,210 | $20K | 11/18/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 15,680 | $37K | 11/17/2025 |
| Joel Lewis | ▼ Sell | Open Market | 15,680 | $95K | 11/17/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 9,586 | $19K | 11/17/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 9,586 | $58K | 11/17/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 19,701 | $22K | 11/17/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 19,701 | $119K | 11/17/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 2,323 | $3K | 11/17/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 2,323 | $14K | 11/17/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 41,500 | $91K | 11/13/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 41,500 | $227K | 11/13/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 41,500 | $104K | 11/13/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 41,500 | $227K | 11/13/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 16,250 | $89K | 11/13/2025 |
| Khurram Jamil | ▼ Sell | Open Market | 21,867 | $120K | 11/13/2025 |
| Khurram Jamil | ▲ Buy | Option Exercise | 16,250 | $20K | 11/13/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 40,000 | $210K | 11/11/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 1,867 | $4K | 11/10/2025 |
| Joel Lewis | ▼ Sell | Open Market | 1,867 | $11K | 11/10/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,675 | $2K | 11/10/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,736 | $10K | 11/10/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,675 | $10K | 11/10/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,736 | $2K | 11/10/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,880 | $4K | 11/10/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,880 | $11K | 11/10/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 200 | $478 | 11/5/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 200 | $396 | 11/5/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 200 | $1K | 11/5/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 200 | $222 | 11/5/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 200 | $1K | 11/5/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 200 | $344 | 11/5/2025 |
| Joel Lewis | ▼ Sell | Open Market | 200 | $1K | 11/5/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 200 | $1K | 11/5/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 10,741 | $65K | 11/4/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 10,741 | $18K | 11/4/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 8,974 | $10K | 11/4/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 8,974 | $54K | 11/4/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 14,420 | $34K | 11/4/2025 |
| Joel Lewis | ▼ Sell | Open Market | 14,420 | $88K | 11/4/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 8,914 | $54K | 11/4/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 8,914 | $18K | 11/4/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 1,300 | $3K | 11/3/2025 |
| Joel Lewis | ▼ Sell | Open Market | 1,300 | $8K | 11/3/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,300 | $3K | 11/3/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,300 | $8K | 11/3/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,260 | $1K | 11/3/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 1,250 | $2K | 11/3/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,250 | $8K | 11/3/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 1,260 | $8K | 11/3/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 20,000 | $99K | 10/22/2025 |
| 10X Fund, L.P. | ▼ Sell | Open Market | 30,000 | $148K | 10/22/2025 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 8,706 | $12K | 9/12/2025 |
| Jack W. Callicutt | ▼ Sell | Open Market | 8,706 | $56K | 9/12/2025 |
| Joel Lewis | ▲ Buy | Option Exercise | 14,000 | $33K | 9/12/2025 |
| Joel Lewis | ▼ Sell | Open Market | 14,000 | $89K | 9/12/2025 |
| Kary Eldred | ▲ Buy | Open Market | 1,000 | $3K | 7/21/2025 |
| Kevin D. Freeman | ▲ Buy | Open Market | 5,000 | $14K | 7/17/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 46,875 | $112K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 25,000 | $118K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 30,000 | $86K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 40,000 | $84K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 70,000 | $148K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 40,000 | $79K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 40,000 | $44K | 6/6/2025 |
| CZIRR JAMES C | ▲ Buy | Option Exercise | 31,250 | $28K | 6/6/2025 |
| CZIRR JAMES C | ▼ Sell | Other | 1,000 | $6K | 3/31/2025 |
| Joel Lewis | ▲ Buy | Grant | 56,420 | $89K | 3/3/2025 |
| CZIRR JAMES C | ▼ Sell | Gift | 10,000 | — | 2/4/2025 |
| CZIRR JAMES C | ▼ Sell | Gift | 10,000 | — | 2/3/2025 |
| Richard E. Uihlein | ▲ Buy | Grant | 32,520 | $40K | 1/23/2025 |
| Harold H. Shlevin | ▲ Buy | Open Market | 6,500 | $8K | 12/30/2024 |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 10,000 | $8K | 12/24/2024 |
| Kary Eldred | ▲ Buy | Open Market | 13,469 | $11K | 12/24/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 10,000 | $8K | 12/24/2024 |
| Khurram Jamil | ▲ Buy | Option Exercise | 40,000 | $0 | 12/23/2024 |
| Khurram Jamil | ▼ Sell | Open Market | 13,654 | $12K | 12/23/2024 |
| Joel Lewis | ▲ Buy | Option Exercise | 56,000 | $0 | 12/23/2024 |
| Joel Lewis | ▼ Sell | Open Market | 56,000 | $50K | 12/23/2024 |
| Jack W. Callicutt | ▲ Buy | Option Exercise | 40,000 | $0 | 12/23/2024 |
| Jack W. Callicutt | ▼ Sell | Open Market | 40,000 | $35K | 12/23/2024 |
| Kary Eldred | ▲ Buy | Open Market | 500 | $1K | 10/23/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 1,300 | $3K | 10/17/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 5,000 | $14K | 10/16/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 5,000 | $14K | 10/16/2024 |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 1,759 | $4K | 8/23/2024 |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 1,000 | $2K | 8/23/2024 |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 741 | $2K | 8/22/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 2,500 | $6K | 6/20/2024 |
| Zordani Richard A. Jr. | ▲ Buy | Open Market | 1,000 | $4K | 4/30/2024 |
| Joel Lewis | ▲ Buy | Open Market | 1,000 | $3K | 4/24/2024 |
| CZIRR JAMES C | ▼ Sell | Open Market | 3,677 | $11K | 4/23/2024 |
| CZIRR JAMES C | ▼ Sell | Open Market | 21,323 | $65K | 4/22/2024 |
| Kevin D. Freeman | ▲ Buy | Open Market | 2,500 | $7K | 4/22/2024 |
| Kevin D. Freeman | ▼ Sell | Other | 2,063 | $0 | 4/9/2024 |
| Joel Lewis | ▲ Buy | Grant | 152,584 | $299K | 3/1/2024 |
| Richard E. Uihlein | ▲ Buy | Grant | 23,256 | $40K | 1/24/2024 |
| Kary Eldred | ▲ Buy | Open Market | 500 | $893 | 1/16/2024 |
| Kary Eldred | ▲ Buy | Open Market | 400 | $956 | 1/16/2024 |
| Joel Lewis | ▲ Buy | Grant | 11,606 | $19K | 12/29/2023 |
| Joel Lewis | ▲ Buy | Grant | 12,042 | $19K | 12/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 9,880 | $19K | 11/30/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,303 | $19K | 11/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 9,444 | $19K | 10/31/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,035 | $20K | 10/13/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,035 | $19K | 9/29/2023 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 200,000 | $600K | 9/26/2023 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 1,466,204 | $7.3M | 9/26/2023 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 170,000 | $850K | 9/26/2023 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 200,000 | $600K | 9/26/2023 |
| Richard E. Uihlein | ▲ Buy | Option Exercise | 200,000 | $652K | 9/26/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,947 | $19K | 9/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 11,010 | $19K | 8/31/2023 |
| Joel Lewis | ▲ Buy | Grant | 12,042 | $19K | 8/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 12,844 | $19K | 7/31/2023 |
| Kary Eldred | ▲ Buy | Open Market | 1,598 | $3K | 7/19/2023 |
| Joel Lewis | ▲ Buy | Grant | 11,820 | $19K | 7/14/2023 |
| Joel Lewis | ▲ Buy | Grant | 13,380 | $19K | 6/30/2023 |
| Joel Lewis | ▲ Buy | Grant | 13,196 | $19K | 6/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 12,272 | $19K | 5/31/2023 |
| Joel Lewis | ▲ Buy | Grant | 11,748 | $19K | 5/15/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,947 | $19K | 4/28/2023 |
| Joel Lewis | ▲ Buy | Grant | 9,585 | $19K | 4/14/2023 |
| Joel Lewis | ▲ Buy | Grant | 9,175 | $19K | 3/31/2023 |
| Joel Lewis | ▲ Buy | Grant | 10,140 | $19K | 3/15/2023 |
| Joel Lewis | ▼ Sell | Tax Withholding | 75,529 | $156K | 3/1/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Galectin Clears Balance Sheet with $105M Debt Conversion
Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.
Galectin Clears Balance Sheet with $105M Debt Conversion. Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.